VictorViaud

Associate

Paris + 33.1.56.59.39.35

Victor Viaud's practice covers all aspects of European and French competition law. He has experience in antitrust, merger control, and state aid counseling and litigation in a wide range of sectors, including energy, technology, and transportation. He also has worked in Jones Day's Brussel Office.

Erfahrung

  • Tender offer for Eurobio Scientific launched by NextStage AM and IK PartnersJones Day is advising Eurobio Scientific SA in the tender offer launched by a consortium led by the management of Eurobio Scientific and funds managed by NextStage AM and IK Investment Partners, at a price of €25.3 per share increased by €1.25 per share if the threshold of 90% of Eurobio Scientific's capital and voting rights is reached, representing a maximum amount of approximately €161 million and valuating Eurobio Scientific at approximately €270 million.
  • Orange forms joint venture with Capgemini to launch BleuJones Day acted as antitrust counsel in the formation of a joint venture between Orange and Capgemini to launch Bleu in a strategic partnership with Microsoft, with the aim of meeting the specific cloud needs of the French State, public agencies, hospitals, regional authorities, Vital Importance Operators (OIVs) and Essential Service Operators (OSEs) enabling them to use Microsoft 365 and Microsoft Azure services.
  • TotalEnergies completes PIPE investment in NextDecade Corporation and investment in $18.5 billion Rio Grande LNG ProjectJones Day represented TotalEnergies in connection with its PIPE investment in NextDecade Corporation and investment in the Rio Grande LNG (RGLNG) Project, a planned natural gas liquefaction project in South Texas.
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Sanofi divests IMOJEV® to SUBSTIPHARMJones Day advised Sanofi in the sale of the Japanese Encephalitis vaccine IMOJEV® to SUBSTIPHARM, a privately held pharmaceutical group.
  • Deezer merges with and into I2PO S.A.Jones Day advised Deezer S.A. in the context of the SPAC transaction whereby Deezer S.A. merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • Armor sells stake in ARMOR-IIMAK to AstorgJones Day advised EN5, controlling shareholders of the Armor group, on the management buyout of Armor Iimak group and the simultaneous 40% investment by Astorg Midcap in the Armor Iimak group.
  • Orange forms joint venture with PublicisJones Day acted as antitrust counsel in the formation of a joint venture between Orange and Publicis for the marketing of a cloud platform to professionals for the production of hybrid events, accessible in Software as a Service (‘SaaS’) mode.
  • EDF obtains full dismissal of antitrust complaint in FranceJones Day secured the complete dismissal of a complaint brought against EDF (Electricité de France) by a French association of energy retailers, l'ANODE, before the French Competition Authority ("FCA").
  • Reno De Medici sells 100% interest in R.D.M. La Rochette S.A.S.Jones Day advised Reno De Medici SpA in the sale of its 100% interest in R.D.M. La Rochette S.A.S. to La Rochette Holding S.A.S., 100% owned by Mutares SE & Co. KgaA.
  • Total acquires Fonroche BiogazJones Day advised Total in the acquisition of Fonroche Biogaz, a company that designs, builds and operates anaerobic digestion units in France.
  • Macquarie Infrastructure and Real Assets divests stakes in Autoroutes Paris-Rhin-RhoneJones Day advised Macquarie Infrastructure and Real Assets (Europe) Limited in the sale by subsidiaries Macquarie Infrastructure Fund 2, Macquarie Mercer Infrastructure Trust 1, and Macquarie Mercer Infrastructure Trust 2 of remaining stakes in Autoroutes Paris-Rhin-Rhone for an aggregate price of €867 million.